PTCT

PTC THERAPEUTICS, INC.

Healthcare · Biotechnology

$301.47 sample

+3.47 (+1.16%) 1D

Market cap

$700.0B

Price as of

2026-10-05

Latest filing

8-K

Alerts

8

Price$301.47 +7.03% 3M daily closessample

305.39276.43

2026-07-082026-07-302026-08-212026-09-112026-10-05

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 29INSInsider sell: General Counsel
Sep 23INSInsider sell: EVP, Operations
Sep 18INSInsider sell: 10% owner
Sep 15INSInsider sell: Director
Sep 09INSInsider sell: 10% owner
Sep 03INSInsider sell: Director
Aug 26INSInsider buy: Chief Executive Officer
Aug 19INSInsider sell: Director

Sign up to see the real PTCT record →

Company facts

SEC EDGAR registration

Name: PTC THERAPEUTICS, INC.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -48sample, -100 to +100
Reporting currency: USD

Who is positioning in PTCT

sample

Insiders: 22 insider transactions over 90 days, net selling, $723.4M
Congress: No member trades over 90 days
Institutions · 13F: 23 funds hold $15.5B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$18.7B +10.4% y/y

Q4 2024Q3 2026

Inventory$11.5B +18.7% y/y

Q4 2024Q3 2026

Accounts receivable$8.8B +12.4% y/y

Q4 2024Q3 2026

Total debt$22.6B +14.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $253.9B +11.3% 3M
Sample peer B: $548.1B -12.4% 3M
Sample peer C: $654.7B +0.3% 3M
Sample peer D: $342.0B -6.1% 3M
Sample peer E: $374.4B -6.0% 3M